Cadence Pharmaceuticals, Inc.

166 articles about Cadence Pharmaceuticals, Inc.

• Mallinckrodt Pharmaceuticals Completes $1.4 Billion Acquisition Of Cadence Pharmaceuticals, Inc.

  3/19/2014

• Cadence Pharmaceuticals, Inc. Reports Fourth Quarter And Full Year 2013 Financial Results

  3/3/2014

• Mallinckrodt Pharmaceuticals Adds Pain Drug With $1.3 Billion Cash Cadence Pharmaceuticals, Inc. Buyout

  2/11/2014

• Cadence Pharmaceuticals, Inc. Estimates Fourth Quarter And Full Year 2013 Product Revenue And Provides Full Year 2014 Revenue Guidance

  1/13/2014

• Cadence Pharmaceuticals, Inc. Release: New Data Detailing Economic Impact Of IV Acetaminophen In Treating Acute Pain To Be Presented At Two Major Healthcare Conferences

  12/9/2013

• Cadence Pharmaceuticals, Inc.' CEO Ted Schroeder To Present At The 25th Annual Cadence Pharmaceuticals, Inc. Healthcare Conference On December 4, 2013

  11/27/2013

• Cadence Pharmaceuticals, Inc. Reports Positive Outcome In OFIRMEV® Patent Litigation

  11/15/2013

• Cadence Pharmaceuticals, Inc. Recognized As A Top Workplace In San Diego Based On Employee Feedback

  11/11/2013

• Cadence Pharmaceuticals, Inc. Reports Third Quarter 2013 Financial Results

  11/6/2013

• Cadence Pharmaceuticals, Inc. to Host Conference Call and Webcast to Discuss Third Quarter 2013 Financial Results on November 5, 2013

  10/30/2013

• Cadence Pharmaceuticals, Inc.' CEO Ted Schroeder to Present at the Stifel Nicolaus Healthcare Conference 2013 on September 11, 2013

  9/5/2013

• Cadence Pharmaceuticals, Inc. Comments on USPTO's Non-Final, Initial Office Action on Reexamination of Patent

  8/16/2013

• Cadence Pharmaceuticals, Inc. Appoints Laureen DeBuono to its Board of Directors

  8/15/2013

• Cadence Pharmaceuticals, Inc. to Present at the 2013 Wedbush PacGrow Life Sciences Management Access Conference on August 13, 2013

  8/7/2013

• Cadence Pharmaceuticals, Inc. Reports Second Quarter 2013 Financial Results

  8/1/2013

• Cadence Pharmaceuticals, Inc. to Host Conference Call And Webcast to Discuss Second Quarter 2013 Financial Results on July 31, 2013

  7/25/2013

• Cadence Pharmaceuticals, Inc. to Present at the 8th Annual JMP Securities Healthcare Conference on July 9, 2013

  7/3/2013

• Cadence Pharmaceuticals, Inc. to Present at Three Investment Conferences During the Month of May 2013

  5/9/2013

• Cadence Pharmaceuticals, Inc. Reports First Quarter 2013 Financial Results

  5/3/2013

• Cadence Pharmaceuticals, Inc. to Host Conference Call and Webcast to Discuss First Quarter 2013 Financial Results on May 2, 2013

  4/26/2013